Edition:
United States

NxStage Medical Inc (NXTM.OQ)

NXTM.OQ on NASDAQ Stock Exchange Global Select Market

30.00USD
21 Feb 2019
Change (% chg)

$0.01 (+0.03%)
Prev Close
$29.99
Open
$30.00
Day's High
$30.00
Day's Low
$29.98
Volume
310,782
Avg. Vol
165,817
52-wk High
$30.00
52-wk Low
$23.17

Select another date:

Wed, Feb 20 2019

Photo

FMC expects NxStage deal to close in next couple of days

BERLIN Germany's Fresenius Medical Care (FMC) said on Wednesday it has won the green light from U.S. regulators to acquire U.S. home dialysis equipment maker NxStage and expects the deal to close in the next few days.

FMC expects NxStage deal to close in next couple of days

BERLIN, Feb 20 Germany's Fresenius Medical Care (FMC) said on Wednesday it has won the green light from U.S. regulators to acquire U.S. home dialysis equipment maker NxStage and expects the deal to close in the next few days.

U.S. approves Fresenius purchase of NxStage

WASHINGTON The U.S. Federal Trade Commission has given Germany's Fresenius Medical Care AG and U.S. home dialysis equipment maker NxStage Medical Inc antitrust approval for their merger, the agency said on Tuesday.

UPDATE 2-U.S. approves Fresenius purchase of NxStage

WASHINGTON, Feb 19 The U.S. Federal Trade Commission has given Germany's Fresenius Medical Care AG and U.S. home dialysis equipment maker NxStage Medical Inc antitrust approval for their merger, the agency said on Tuesday.

US approves Fresenius purchase of NxStage with conditions

WASHINGTON, Feb 19 The U.S. Federal Trade Commission has given Fresenius Medical Care AG and NxStage Medical Inc antitrust approval for their merger with conditions, the agency said on Tuesday. (Reporting by Diane Bartz Editing by James Dalgleish)

FMC extends deadline for NxStage deal until August 6 due to U.S. government shutdown

BERLIN Germany's Fresenius Medical Care (FMC) said on Tuesday it had agreed to extend the deadline for its planned $2 billion takeover of U.S. home dialysis equipment maker NxStage Medical Inc until August 6.

FMC extends deadline for NxStage deal until Aug. 6 due to U.S. government shutdown

BERLIN, Jan 29 Germany's Fresenius Medical Care (FMC) said on Tuesday it had agreed to extend the deadline for its planned $2 billion takeover of U.S. home dialysis equipment maker NxStage Medical Inc until August 6.

UPDATE 2-Fresenius Medical Care says expects weaker growth in Q4

* Deadline for NxStage Medical takeover extended (Adds share price, analyst)

Select another date: